What happens if I overdose Betnovate Scalp Application?
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local, or emergency room immediately.
Proper storage of Betnovate Scalp Application solution:
Store Betnovate Scalp Application solution at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Betnovate Scalp Application solution out of the reach of children and away from pets.
Overdose of Betnovate Scalp Application in details
When a dose is taken in higher dose than the recommended doses, it is called Overdose. Overdose always needs a clinical supervision. Any medicine or drug when consumed in Overdose produces untoward side effects on one or various organs in the body. A medicine is excreted in the kidney or metabolized in the liver most of the times. This process goes without any hurdles when taken in normal dose, but when taken in an overdose, the body is not able to metabolize it or send it out properly which causes the effects of anoverdose.
Symptoms: Excessive or prolonged use of topical corticosteroids can suppress pituitary-adrenal function, resulting in secondary adrenal insufficiency and produce manifestations of hypercorticism, including Cushing's disease.
A single overdose of gentamicin would not be expected to produce symptoms. Excessive or prolonged use of topical antibiotics may lead to overgrowth of lesions by non-susceptible organisms.
Systemically, tolnaftate is pharmacologically inactive.
Clioquinol rarely produces iodism.
Treatment: Appropriate symptomatic treatment is indicated. Acute hypercorticoid symptoms are usually reversible. Treat electrolyte imbalance, if necessary. In case of chronic toxicity, slow withdrawal of corticosteroids is advised.
If overgrowth by non-susceptible organisms occurs, stop treatment with Betnovate Scalp Application, Gentamicin, Tolnaftate, Clioquinol (Betnovate Scalp Application) Cream and institute appropriate therapy.
What should I avoid while taking Betnovate Scalp Application?
Avoid getting this medicine in your eyes. If contact does occur, rinse with water. Do not use Betnovate Scalp Application topical on broken or infected skin. Also avoid using this medicine in open wounds.
Avoid applying Betnovate Scalp Application topical to the skin of your face, underarms, or groin area without your doctor's instruction.
Do not use Betnovate Scalp Application topical to treat any condition that has not been checked by your doctor.
Betnovate Scalp Application warnings
Warnings are a mix of Precautions. Contraindications and interactions and serious harmful effects associated with the medicine intake. A diabetic or Hypertensive patient need to be warned about few drug interactions. A known hypersensitivity patient needs to be careful about the reactions or anaphylactic shock. A pregnant woman or a breastfeeding woman should be warned of certain medications. A Hepatitis [liver disease] patient or a cardiac patient should avoid few drugs.
Do not use if you are
pregnant or intend to
become pregnant, or
should not be used if you
have a skin infection.
Betnovate Scalp Application should not
be used in children under
the age of 1 year, unless
advised by your doctor.
Do not use Betnovate Scalp Application
after the expiry date
(EXP.) printed on the
If you use it after the expiry
date has passed, it may
have no effect at all, or worse, it may give an
entirely unexpected effect.
Do not use Betnovate Scalp Application if
the packaging shows signs
of tampering or if the seal
on the tube is broken, or
if the product does not
look quite right.
If it has expired or is
damaged, return it to your
pharmacist for disposal.
Before you start to use it
You must tell your doctor
• You are allergic to any
other medicines, foods,
dyes or preservatives.
• You have any other
especially if you have
• You are pregnant or
intend to become
• You are breast-feeding
or intend to breastfeed.
If you have not told your
doctor about any of the
above, tell them before
you start to use
Betnovate Scalp Application.
Use in Children
Betnovate Scalp Application is not
recommended for use in
children, unless your doctor
tells you to do so.
using Betnovate Scalp Application if an
irritation or sensitisation
Do not use Betnovate Scalp Application
under occlusive dressings
(airtight covering) or on
large areas of skin unless
your doctor tells you to.
Do not use Betnovate Scalp Application in
or near the eyes.
Do not stop using
Betnovate Scalp Application or change the
amount, area or method of
application, without first
checking with your doctor.
Do not give Betnovate Scalp Application to
anyone else even if his or
her symptoms seem similar
Do not use plastic pants or
tight-fitting nappies if
Betnovate Scalp Application is to be used
on the nappy area of young
Do not use Betnovate Scalp Application to
treat any other conditions
unless your doctor tells you
to do so.
Do not use large amounts
of Betnovate Scalp Application for a long
period of time.
If you use large amounts
for a long time, the chance
of systemic absorption
through the skin and the
chance of side effects may
Only use Betnovate Scalp Application on
skin areas that rub together
such as under the arm or in
the groin area if your
doctor tells you to.
Only use Betnovate Scalp Application on
the face if your doctor tells
you to. If improvement
does not occur within one
week, tell your doctor
Children and adolescents
should be followed closely
by the doctor, since this
medicine is absorbed
through the skin and can
affect growth or cause
other unwanted side
What should I discuss with my healthcare provider before taking Betnovate Scalp Application?
Some medical conditions may interact with Betnovate Scalp Application solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
if you are pregnant, planning to become pregnant, or are breast-feeding
if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
if you have allergies to medicines, foods, or other substances
if you have recently had or are scheduled to have a vaccination
if you have a history of an underactive thyroid, liver or kidney problems, heart problems or heart attack, diabetes, high blood pressure, inflammation of the esophagus, stomach problems (eg, ulcers), bowel blockage or other bowel problems (eg, ulcerative colitis), recent bowel surgery, myasthenia gravis, bone problems (eg, osteoporosis), or mental or mood problems (eg, depression)
if you have diarrhea, measles, chickenpox, herpes infection of the eye, or any other type of bacterial, fungal, parasitic, or viral infection
if you have recently had tuberculosis (TB) or have had a positive skin test for TB
Some MEDICINES MAY INTERACT with Betnovate Scalp Application solution. Tell your health care provider if you are taking any other medicines, especially any of the following:
Aprepitant because they may increase the risk of Betnovate Scalp Application solution's side effects
Barbiturates (eg, phenobarbital), carbamazepine, hydantoins (eg, phenytoin), or rifampin because they may decrease Betnovate Scalp Application solution's effectiveness
Clarithromycin, azole antifungals (eg, ketoconazole), steroidal contraceptives (eg, desogestrel), or troleandomycin because side effects, such as weakness, confusion, muscle aches, joint pain, or low blood sugar, may occur
Methotrexate or ritodrine because the risk of their side effects may be increased by Betnovate Scalp Application solution
Hydantoins (eg, phenytoin), live vaccines. or mifepristone because their effectiveness may be decreased by Betnovate Scalp Application solution
Anticoagulants (eg, warfarin) or aspirin because the actions and side effects of these medicines may be increased or decreased by Betnovate Scalp Application solution
This may not be a complete list of all interactions that may occur. Ask your health care provider if Betnovate Scalp Application solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Betnovate Scalp Application precautions
Certain people who are very sick or very old or who are sensitive show an exacerbation of side effect of the drug which can turn dangerous at times. So, it is very important to remember the precautions while taking the medicine. Pregnancy and Breastfeeding are also special categories wherein extra care or precaution is needed when taking a drug. Few patients may have a hypersensitivity reaction to few medications, and that can be life-threatening rarely. Penicillin hypersensitivity is one example. Diarrhea, rashes are few other symptoms which need a watch. A patient with other co-existing diseases like liver disease, heart disease, kidney disease should take special precautions.
If irritation or sensitization develops with the use of Betnovate Scalp Application, Gentamicin, Tolnaftate, Clioquinol (Betnovate Scalp Application) Cream, treatment should be discontinued and appropriate therapy instituted.
Any of the side effects that are reported following systemic use of corticosteroids, including adrenal suppression may also occur with topical corticosteroids, especially in infants and children.
Systemic absorption of Betnovate Scalp Application, Gentamicin, Tolnaftate, Clioquinol (Betnovate Scalp Application) Cream will be increased if extensive body surface areas are treated or if the occlusive technique is used. Suitable precautions should be taken under these conditions or when long-term use is anticipated, particularly in infants and children.
Cross-allergenicity among aminoglycosides has been demonstrated.
Systemic absorption of topically applied gentamicin may be increased if extensive body surface areas are treated, especially over prolonged time periods or in the presence of dermal disruption. In these cases, the undesirable effects which occur following systemic use of gentamicin may potentially occur. Cautious use is recommended under these conditions, particularly in infants and children.
Prolonged use of topical antibiotics occasionally may result in overgrowth of non-susceptible organisms. If this occurs or if irritation, sensitization or superinfection develops, treatment with Betnovate Scalp Application, Gentamicin, Tolnaftate, Clioquinol (Betnovate Scalp Application) Cream should be discontinued and appropriate therapy instituted. Slight staining of linens or clothing due to clioquinol may occur.
Betnovate Scalp Application, Gentamicin, Tolnaftate, Clioquinol (Betnovate Scalp Application) Cream is not for ophthalmic use.
Use in Children: Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hypothalamic-pituitaryadrenal (HPA) axis suppression and to exogenous corticosteroids effects than mature patients because of greater absorption due to large skin surface area to body weight ratio.
HPA axis suppression, Cushing's syndrome, linear growth retardation, delayed weight gain, and intracranial hypertension have been reported in children receiving topical corticosteroids. Manifestations of adrenal suppression in children include low plasmacortisol levels and absence of response to ACTH stimulation. Manifestations of intracranial hypertension include a bulging fontanelle, headaches and bilateral papilledema.
What happens if I miss a dose of Betnovate Scalp Application?
When you miss a dose, you should take it as soon as you remember, but you should take care that it should be well spaced from the next dose. You should not take an extra dose at the time of the second dose as it will become a double dose. The double dose can give unwanted side effects, so be careful. In chronic conditions or when you have a serious health issue, if you miss a dose, you should inform your health care provider and ask his suggestion.
Call your doctor for instructions if you miss an appointment for your Betnovate Scalp Application injection.
DailyMed. "BETAMETHASONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).